Matthew Robertson
Author
Matthew Robertson is the former China news editor for The Epoch Times. He was previously a reporter for the newspaper in Washington, D.C. In 2013 he was awarded the Society of Professional Journalists’ Sigma Delta Chi award for coverage of the Chinese regime's forced organ harvesting of prisoners of conscience.
LATEST
A Day to Remember Victims of Organ Harvesting in China
A nongovernmental medical advocacy group has marked Oct. 1 as the “international day against forced organ harvesting.
|
Deleting a Question and Declining an Answer on Organ Transplant Reform in China
A Chinese state-backed NGO recently endorsed use of organs from prisoners, contradicting public statements.
|
Rebel Transplant Conference Held in Hong Kong
Nearby The Transplantation Society’s annual congress in Hong Kong, another forum took place—one focusing on the genocidal abuse of transplantation in China
|
Acrimony Mars Transplant Conference in Hong Kong
What was supposed to be a celebration of organ transplant reform in China has descended into contention and conflict.
|
International Transplant Leaders’ Undisclosed Ties to China Raise Ethical Questions
Potentially lucrative treatment for diabetes, developed in China, not divulged, as doctors pronounced on Chinese ‘reform’
|
|
A Day to Remember Victims of Organ Harvesting in China
A nongovernmental medical advocacy group has marked Oct. 1 as the “international day against forced organ harvesting.
|
Deleting a Question and Declining an Answer on Organ Transplant Reform in China
A Chinese state-backed NGO recently endorsed use of organs from prisoners, contradicting public statements.
|
Rebel Transplant Conference Held in Hong Kong
Nearby The Transplantation Society’s annual congress in Hong Kong, another forum took place—one focusing on the genocidal abuse of transplantation in China
|
Acrimony Mars Transplant Conference in Hong Kong
What was supposed to be a celebration of organ transplant reform in China has descended into contention and conflict.
|
International Transplant Leaders’ Undisclosed Ties to China Raise Ethical Questions
Potentially lucrative treatment for diabetes, developed in China, not divulged, as doctors pronounced on Chinese ‘reform’
|
|